journal article·2024-03Open access

Metabolic Bypass Rescues Aberrant S‐nitrosylation‐Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons

Alexander Y. Andreyev, Hongmei Yang, Paschalis‐Thomas Doulias, Nima Dolatabadi, Xu Zhang, Melissa Luevanos, Mayra Blanco, Christine Baal, Ivan Putra, Tomohiro Nakamura, Harry Ischiropoulos, Steven R. Tannenbaum, Stuart A. Lipton

Advanced Science· Volume 11· Issue 12

Abstract

Abstract In Alzheimer's disease (AD), dysfunctional mitochondrial metabolism is associated with synaptic loss, the major pathological correlate of cognitive decline. Mechanistic insight for this relationship, however, is still lacking. Here, comparing isogenic wild‐type and AD mutant human induced pluripotent stem cell (hiPSC)‐derived cerebrocortical neurons (hiN), evidence is found for compromised mitochondrial energy in AD using the Seahorse platform to analyze glycolysis and oxidative phosphorylation (OXPHOS). Isotope‐labeled metabolic flux experiments revealed a major block in activity in the tricarboxylic acid (TCA) cycle at the α‐ketoglutarate dehydrogenase (αKGDH)/succinyl coenzyme‐A synthetase step, metabolizing α‐ketoglutarate to succinate. Associated with this block, aberrant protein S‐nitrosylation of αKGDH subunits inhibited their enzyme function. This aberrant S‐nitrosylation is documented not only in AD‐hiN but also in postmortem human AD brains versus controls, as assessed by two separate unbiased mass spectrometry platforms using both SNOTRAP identification of S‐nitrosothiols and chemoselective‐enrichment of S‐nitrosoproteins. Treatment with dimethyl succinate, a cell‐permeable derivative of a TCA substrate downstream to the block, resulted in partial rescue of mitochondrial bioenergetic function as well as reversal of synapse loss in AD‐hiN. These findings have therapeutic implications that rescue of mitochondrial energy metabolism can ameliorate synaptic loss in hiPSC‐based models of AD.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mitochondrial Function and Pathology · Alzheimer's disease research and treatments · Neuroscience and Neuropharmacology Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Molecular Medicine and Neurodegeneration New Medicines Center The Scripps Research Institute La Jolla CA 92037 USA

Department of Biological Engineering Massachusetts Institute of Technology Cambridge MA 02139 USA

Northeast Asia Institute of Chinese Medicine Changchun University of Chinese Medicine Changchun 130021 China

Children's Hospital of Philadelphia Research Institute and Departments of Pediatrics and Pharmacology Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania Philadelphia PA 19104 USA

Department of Chemistry and Institute of Biosciences University Research Center of Ioannina University of Ioannina Ioannina 45110 Greece

Department of Neurosciences School of Medicine University of California at San Diego La Jolla CA 92093 USA

Funding

National Institutes of Health · National Institute on Drug Abuse · National Institute of Neurological Disorders and Stroke · National Institute on Aging

References (65)

Show source-provided references
1. 10.1016/j.bbadis.2009.08.01010.1016/j.bbadis.2009.08.010 ↗
2. 10.1111/acel.1292410.1111/acel.12924 ↗
3. 10.3390/antiox1210181610.3390/antiox12101816 ↗
4. 10.1126/scitranslmed.abk105110.1126/scitranslmed.abk1051 ↗
5. 10.1002/ana.41027050210.1002/ana.410270502 ↗
6. 10.1002/ana.41030041010.1002/ana.410300410 ↗
7. 10.1038/s41582-022-00749-z10.1038/s41582-022-00749-z ↗
8. 10.1016/j.jbc.2022.10283810.1016/j.jbc.2022.102838 ↗
9. 10.1007/s13365-021-00970-410.1007/s13365-021-00970-4 ↗
10. 10.1016/j.chembiol.2023.06.01810.1016/j.chembiol.2023.06.018 ↗
11. 10.1126/sciadv.ade076410.1126/sciadv.ade0764 ↗
12. 10.1073/pnas.100803610710.1073/pnas.1008036107 ↗
13. 10.1016/j.jprot.2013.05.03310.1016/j.jprot.2013.05.033 ↗
14. Ghatak S. · eLife · 2019 · 9 · 8
15. 10.1038/s41380-020-0776-710.1038/s41380-020-0776-7 ↗
16. 10.1038/nature1766410.1038/nature17664 ↗
17. 10.1016/j.neuron.2015.03.03510.1016/j.neuron.2015.03.035 ↗
18. 10.1038/nrn.2018.1910.1038/nrn.2018.19 ↗
19. 10.1073/pnas.91.22.1062510.1073/pnas.91.22.10625 ↗
20. 10.1016/j.cmet.2017.06.02110.1016/j.cmet.2017.06.021 ↗
21. 10.1016/j.neuron.2022.03.01510.1016/j.neuron.2022.03.015 ↗
22. 10.1038/s41583-021-00535-810.1038/s41583-021-00535-8 ↗
23. 10.1073/pnas.221200411910.1073/pnas.2212004119 ↗
24. 10.1007/978-1-4939-9236-2_1410.1007/978-1-4939-9236-2_14 ↗
25. 10.1016/bs.mie.2015.06.02610.1016/bs.mie.2015.06.026 ↗
26. 10.1016/j.molcel.2022.06.03010.1016/j.molcel.2022.06.030 ↗
27. 10.1016/j.tibs.2019.12.00210.1016/j.tibs.2019.12.002 ↗
28. 10.1073/pnas.130683211010.1073/pnas.1306832110 ↗
29. 10.1016/j.tem.2017.10.00410.1016/j.tem.2017.10.004 ↗
30. 10.1016/j.copbio.2015.02.00310.1016/j.copbio.2015.02.003 ↗
31. 10.1038/s41583-019-0132-610.1038/s41583-019-0132-6 ↗
32. 10.1016/j.cell.2018.03.05510.1016/j.cell.2018.03.055 ↗
33. 10.1016/j.molcel.2014.05.00810.1016/j.molcel.2014.05.008 ↗
34. reyev A. Y. · Biol. Med. · 2015 · 82 · 63
35. 10.1016/j.cell.2013.11.00910.1016/j.cell.2013.11.009 ↗
36. 10.1016/j.cmet.2022.07.01410.1016/j.cmet.2022.07.014 ↗
37. 10.1038/nature1390910.1038/nature13909 ↗
38. 10.1016/j.ccr.2004.11.02210.1016/j.ccr.2004.11.022 ↗
39. 10.1038/cddis.2016.38910.1038/cddis.2016.389 ↗
40. 10.1038/s41586-021-04059-010.1038/s41586-021-04059-0 ↗
41. 10.1126/science.117109110.1126/science.1171091 ↗
42. 10.1126/scitranslmed.300398510.1126/scitranslmed.3003985 ↗
43. 10.1073/pnas.190057611610.1073/pnas.1900576116 ↗
44. 10.1126/science.aaw084310.1126/science.aaw0843 ↗
45. 10.1038/s41467-018-03241-910.1038/s41467-018-03241-9 ↗
46. 10.1186/alzrt7410.1186/alzrt74 ↗
47. 10.1016/j.stem.2020.08.01310.1016/j.stem.2020.08.013 ↗
48. 10.1126/science.abq105310.1126/science.abq1053 ↗
49. 10.1126/scisignal.200325210.1126/scisignal.2003252 ↗
50. 10.1126/scisignal.aaa431210.1126/scisignal.aaa4312 ↗
51. 10.1093/bib/bbx03110.1093/bib/bbx031 ↗
52. 10.1073/pnas.152131811310.1073/pnas.1521318113 ↗
53. 10.1038/nprot.2013.09210.1038/nprot.2013.092 ↗
54. 10.1158/1940-6207.CAPR-17-019810.1158/1940-6207.CAPR-17-0198 ↗
55. 10.1126/science.aan466510.1126/science.aan4665 ↗
56. Piyarathna D. · Eur. Urol. Focus · 2018 · 17
57. 10.18632/oncotarget.2103810.18632/oncotarget.21038 ↗
58. 10.1016/j.bpj.2009.03.01110.1016/j.bpj.2009.03.011 ↗
59. 10.1134/S000629792012016010.1134/S0006297920120160 ↗
60. 10.1038/cdd.2012.12810.1038/cdd.2012.128 ↗
61. 10.1038/s41467-019-12372-610.1038/s41467-019-12372-6 ↗
62. 10.1038/s41598-020-60118-y10.1038/s41598-020-60118-y ↗
63. 10.1083/jcb.20181207610.1083/jcb.201812076 ↗
64. 10.1126/scitranslmed.abn938010.1126/scitranslmed.abn9380 ↗
65. A.Frane Type I Error Control in Psychology Research: Improving Understing in General Addressing Multiplicity in Some Specific Contexts. Thesis dissertation UCLA 2019.https://escholarship.org/content/qt8sn0z5g0/qt8sn0z5g0.pdf?t=pw82wy.